Trials / Conditions / Papillomavirus Vaccines

Papillomavirus Vaccines

23 registered clinical trials studyying Papillomavirus Vaccines — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Know NCT07248904	Cukurova University	N/A
Recruiting	Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students NCT07266857	Centre Hospitalier Universitaire de Nice	—
Recruiting	ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention NCT06535139	University of Florida	N/A
Not Yet Recruiting	HPV Vaccine Integrated Service Implementation Research in Cameroon NCT06683664	Population Services International	N/A
Not Yet Recruiting	HPV Vaccine Integrated Service Implementation Research in Ethiopia NCT06667323	Population Services International	N/A
Active Not Recruiting	Let's K-Talk - HPV Study for Ethnic Koreans NCT05884697	University of Cincinnati	N/A
Recruiting	Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV NCT05266898	Louisiana State University Health Sciences Center in New Orleans	Phase 4
Completed	Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers NCT06854354	Hospital Univeristario Benemerita Universidad Autonoma de Puebla	N/A
Active Not Recruiting	Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination NCT05148559	Huong Nguyen, PhD	N/A
Active Not Recruiting	Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors NCT04469569	University of Alabama at Birmingham	N/A
Unknown	Changes in the Prevalence of Oncogenic HPV Types NCT04671823	Kanazawa Medical University	—
Completed	Effectiveness of HPV Vaccine in Thai Adult Women NCT03763565	Mahidol University	—
Unknown	Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination NCT03350698	Eastern Virginia Medical School	Phase 4
Completed	Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination NCT03501992	Mayo Clinic	N/A
Completed	AFIX to Improve HPV Vaccination NCT02370459	University of North Carolina, Chapel Hill	N/A
Completed	Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Viru NCT01031069	GlaxoSmithKline	Phase 4
Terminated	A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-I NCT00798265	National Cancer Institute (NCI)	Phase 1
Completed	Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Su NCT00877877	GlaxoSmithKline	Phase 3
Completed	Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) NCT00637195	GlaxoSmithKline	Phase 3
Completed	Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gard NCT00423046	GlaxoSmithKline	Phase 3
Completed	Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel H NCT00359619	GlaxoSmithKline	Phase 2
Completed	Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age a NCT00294047	GlaxoSmithKline	Phase 3
Completed	Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation. NCT00250276	GlaxoSmithKline	Phase 3